ranimustine
Sign in to saveRanimustine (INN, marketed under the tradename Cymerin; also known as MCNU) is a nitrosourea alkylating agent approved in Japan for the treatment of chronic myelogenous leukemia and polycythemia vera.
Research
233 papersvia PubMed
Wikidata facts
- Mass
- 327.083
Show 4 more facts
- chemical formula
- C₁₀H₁₈ClN₃O₇
- isomeric SMILES
- CO[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CNC(=O)N(CCCl)N=O)O)O)O
- canonical SMILES
- COC1C(C(C(C(O1)CNC(=O)N(CCCl)N=O)O)O)O
- Commons category
- Ranimustine
Sources (2)
via Wikidata · CC0
~2 min read
Article
3 sectionsContents
- Synthesis
- References
- External links
{{Drugbox | verifiedrevid = 448120715 | IUPAC_name = Methyl 6-({[(2-chloroethyl)(nitroso)amino]carbonyl}amino)-6-deoxy-α-D-glucopyranoside | image = Ranimustine (Haworth).svg | image_class = skin-invert-image | width = 215
| tradename = Cymerin | Drugs.com = | pregnancy_AU = | pregnancy_US = | pregnancy_category = | legal_AU = | legal_CA = | legal_UK = | legal_US = | legal_status = Rx-only | routes_of_administration = IV
Connections
tiazofurin
Entity
United States
Country
Japan
Country
medication
Entity
digital object identifier
Entity
leukemia
Entity
chemical formula
Entity
chemotherapy
Entity
amine
Entity
molar mass
Entity
Q180686
Entity
DNA replication
Entity
hydrazine
Entity
cell cycle
Entity
DL-asparagine
Entity
CAS Registry Number
Entity
United States Food and Drug Administration
Entity
PubChem
Entity
microtubule
Entity
Anatomical Therapeutic Chemical Classification System
Entity